Why Medicare Advantage and Medicaid Enrollment Data Goes to the Plan Level (and Commercial Doesn't)

If you're resolving a payer contract list against national enrollment data to calculate market share, you'll run into an asymmetry that looks like a vendor limitation at first: Medicare Advantage and Medicaid enrollment can be broken down to the individual named plan product. Commercial enrollment can't. It stops at the carrier's legal entity name, no matter whose data you're using.

It's not a gap in any one dataset. The data simply doesn't exist to be reported at the plan level for commercial insurance, from any source, including ours.

Treat that as useful information rather than a defect. Most people building a market share model don't know this asymmetry exists, so they build the model as if it doesn't, and the ranking they hand to leadership is quietly apples-to-oranges. If you're the one person in the room who knows why UnitedHealthcare shows up as five rows in Medicare Advantage and one row in commercial, you're the one who can say whether "biggest opportunity" is real or an artifact of reporting structure.

The proof: it's a reporting-structure difference, not a data-quality difference

Medicare Advantage and Medicaid are administered per plan, so they're reported per plan. CMS pays Medicare Advantage organizations, calculates risk adjustment, and publishes Star Ratings on a per-contract, per-plan basis. A single organization like UnitedHealth Group runs dozens of distinct plan products in one state, each with its own bid, its own benefit design, and its own enrollment count. Pulling Arizona as an example, UnitedHealth Group's Medicare Advantage enrollment there isn't one number. It's broken out individually across products, including:

State Medicaid managed care works the same way for the same reason: states contract directly with individual MCO products, which are often branded nothing like their parent company. Arizona's largest Managed Medicaid plan by enrollment, for instance, is "Mercy Care," not "Dignity Health and Carondelet Health Network." Because the state contracts at the product level, the state's own enrollment reporting is at the product level too.

Commercial insurance has no equivalent regulatory structure organized around named products. The closest thing to a federal commercial enrollment dataset is the Medical Loss Ratio (MLR) filing every issuer submits under the ACA, and MLR rebate calculations are performed at the issuer/legal-entity and market-segment level (individual, small group, large group), not per branded product. Pull the same kind of table for a commercial issuer in Arizona and the schema looks like this instead:

There's no plan or product name column in that data at all, because there's no regulatory process that requires, or even permits, CMS to collect one. A carrier can and often does sell a dozen differently branded commercial products under one legal entity, and the MLR filing that entity submits reports them as a single block.

What this means for your market share analysis

• For Medicare Advantage and Medicaid, expect plan-level answers. A contracting gap analysis can tell you not just "you're uncontracted with UnitedHealthcare in Arizona" but which of UnitedHealthcare's specific MA products represent the biggest opportunity.
• For commercial, the finest available grain is the legal entity, from any source. If a vendor claims plan-level commercial enrollment detail, ask them what federal or state filing that number is sourced from. There isn't one. What you're actually being sold is a modeled estimate, usually product names inferred from claims patterns (group numbers, payer IDs, or NPI routing in 837/835 transaction data) and dressed up to look like reported enrollment. That can be a legitimate estimate for some use cases, but it carries sampling and coverage bias that a government filing doesn't, and a vendor who calls it "enrollment data" without saying so is blurring a distinction that matters.
• A market share analysis spanning all three lines of business should say this upfront, not after you've committed. It changes what "biggest opportunity" means for commercial versus MA/Medicaid: legal-entity-level share for one, product-level share for the other.

A pattern we see in payer-strategy and RCM decks (illustrative, not a specific engagement): one "top payers by opportunity" table blends MA enrollment broken out by product with commercial share rolled up to the legal entity, then sorts the whole thing by enrollment count. Every individual MA product looks small next to the one giant commercial row, so the D-SNP or dual-eligible product that's actually the single highest-volume line in the book gets ranked below a commercial entity that's really five or six differently-negotiated products stacked into one number. The fix isn't more data. It's not sorting mismatched grains in the same column.

See it against your own contracts

Medlyze's Payer Network Coverage & Market Share Analysis resolves your existing contract list against enrollment data across commercial, Medicare, Medicare Advantage, Medicaid, and Managed Medicaid, with plan-level detail where it exists and legal-entity detail where that's the ceiling, disclosed either way. Pilot one state first, and the pilot fee is credited in full toward your full rollout if you move forward.

Get a pilot quote →